Rheumatic diseases are intrinsically linked to environmental conditions. With a constantly changing environment, how can rheumatologists adapt to the challenges of global climate change, pollution and other environmental threats? The Environment + Genetics Tamiko Katsumoto, MD, a clinical associate professor in the Division of Immunology and Rheumatology at Stanford University, Palo Alto, Calif., emphasizes the…
Occupational therapist Cheryl Crow, who lives with rheumatoid arthritis, shares the ins and outs of what OT is and how it can help those with rheumatic conditions.
In this study, researchers set out to determine the prevalence of baseline risk factors for cardiovascular outcomes and cancer among commercially insured patients with rheumatoid arthritis during their first dispensed treatment.
This study affirms that dysbiosis is a feature of rheumatoid arthritis (RA) and suggests that specific therapies may differentially modulate the gastrointestinal microbiota in RA.
In a new study published in ACR Open Rheumatology, researchers evaluated the impact of tender-swollen joint difference on functional outcomes in early RA and whether associations vary by joint size.
Two new successful trials in abatacept, APIPPRA and ARIAA, are the first to convincingly demonstrate the potential of a preventive approach to RA treatment.
In a session on a current ACR project on musculoskeletal ultrasound (MSUS), Gurjit Kaeley, MBBS, RhMSUS, MRCP, division chief, professor of medicine, fellowship program director and program director for musculoskeletal ultrasound at the University of Florida College of Medicine, Jacksonville, will present information on proposed guidance related to rheumatoid arthritis. The ACR places a high…
With thousands of research abstracts and posters being presented at ACR Convergence 2024, Nov. 14–19, at the Walter E. Washington Convention Center in Washington, D.C., figuring out which research is important today, which could prove important in the future, what has the potential to affect clinical care or prove the basis for future research is…
On Sunday, Nov. 17, at ACR Convergence 2024, three speakers will deliver a presentation on Rheumatoid Arthritis-Associated Interstitial Lung Disease: Advances in Screening, Diagnosis and Patient Phenotyping. This session will have three 20-minute presentations that cover distinct aspects of RA-associated ILD from early identification of ILD through high-resolution computed tomography (HRCT) text mining, to phenotyping…
As part of the Review Course on Friday Nov. 15 at ACR Convergence 2024, Iain McInnes, MD, will present a session on Challenging Cases in Rheumatoid Arthritis. Case reports represent a healthcare encounter involving a real person with a real clinical problem. They encourage discussions of real-world concerns and experiences, supporting knowledge acquisition and enhancing…